2-Bromo-4-fluoro-1-(pentyloxy)benzene

Catalog No.: 
ACOKDA825
CAS No.: 
1036544-86-1
Molecular Formula: 
C11H14BrFO
Molecular Weight: 
261.13
2-Bromo-4-fluoro-1-(pentyloxy)benzene structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$112.00InquiryInquiry
1g97%$348.00InquiryInquiry
5g97%$1705.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Bromo-4-fluoro-1-(pentyloxy)benzene
IUPAC Name2-bromo-4-fluoro-1-(pentyloxy)benzene
MDL No.MFCD11119485
Molecular FormulaC11H14BrFO
Molecular Weight261.13
SMILESCCCCCOC1=CC=C(F)C=C1Br
InChI KeyDODIATMKNPMFBB-UHFFFAOYSA-N
Synonym1-Bromo-5-fluoro-2-n-pentyloxybenzene;Benzene, 2-bromo-4-fluoro-1-(pentyloxy)-
CAS No.1036544-86-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319
Precautionary Statement(s)
P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362

Synthetic Route by SureRoute

1. ACOKDA825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWJU627 route compound structure diagram
    ACYWJU627496-69-5In Stock
  4. Then
  5. ACOKDA825 route product structure diagram
    ACOKDA8251036544-86-1
Inquiry

2. ACOKDA825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWJU627 route compound structure diagram
    ACYWJU627496-69-5In Stock
  4. Then
  5. ACOKDA825 route product structure diagram
    ACOKDA8251036544-86-1
Inquiry

3. ACOKDA825 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACYWJU627 route compound structure diagram
    ACYWJU627496-69-5In Stock
  4. Then
  5. ACOKDA825 route product structure diagram
    ACOKDA8251036544-86-1
Inquiry

Comments (0)